Target Name: FTL
NCBI ID: G2512
Review Report on FTL Target / Biomarker Content of Review Report on FTL Target / Biomarker
FTL
Other Name(s): ferritin L subunit | Ferritin light polypeptide-like 3 | Ferritin, light polypeptide | FRIL_HUMAN | NBIA3 | Ferritin L subunit | PRO2760 | ferritin, light polypeptide | ferritin light polypeptide-like 3 | LFTD | ferritin light chain | epididymis secretory sperm binding protein | ferritin L-chain | Ferritin light chain

Ferritin L subunit: A Potential Drug Target and Biomarker

I. Introduction

Ferritin is a protein that is synthesized in the liver and is known for its role in the production of hemoglobin, which is responsible for carrying oxygen in the blood. Ferritin has also been shown to have a number of potential drug targets and biomarkers. In this article, we will discuss the ferritin L subunit and its potential as a drug target and biomarker.

II. Ferritin L Subunit: Structure and Function

Ferritin is a transmembrane protein that consists of four subunits. The L subunit is the most abundant and is responsible for the production of ferritin. Ferritin L subunit has a molecular weight of 186 kDa and has a calculated pI of 7.4. Ferritin L subunit has a monomeric structure and is composed of two 伪 subunits and two 尾 subunits. The two 伪 subunits have a catalytic active site and the two 尾 subunits have a peripheral region that interacts with the 伪 subunits.

Ferritin L subunit has a number of potential drug targets. One of the most significant targets is the ferritin-conjugated transmembrane protein (FCMP), which is a protein that is synthesized in the liver and has been shown to interact with ferritin L subunit. FCMP has been shown to play a role in the regulation of cellular processes, including cell signaling, cell adhesion, and cellular migration.

Another potential drug target for ferritin L subunit is the ferritin-like protein (FLP), which is also synthesized in the liver and has been shown to interact with ferritin L subunit. FLP has been shown to play a role in the regulation of cellular processes, including cell signaling, cell adhesion, and cellular migration.

In addition to these potential drug targets, ferritin L subunit has also been shown to have a number of potential biomarkers. One of the most significant biomarkers for ferritin L subunit is the ferritin level in the blood, which is a measure of the amount of ferritin that is present in the blood. Ferritin has been shown to have a number of potential health benefits, including the regulation of oxygen transport, the production of collagen, and the regulation of cellular processes.

III. Potential Therapeutic Applications of Ferritin L Subunit

A. Therapeutic Use of Ferritin L Subunit

One of the potential therapeutic applications of ferritin L subunit is the treatment of anemia. Ferritin L subunit has been shown to have a number of potential mechanisms of action that could be used to treat anemia. For example, ferritin L subunit has been shown to increase the production of erythropoietin (EPO), a protein that is responsible for the production of red blood cells. In addition, ferritin L subunit has been shown to increase the production of hemoglobin (Hb), which is responsible for carrying oxygen in the blood.

Another potential therapeutic application of ferritin L subunit is the treatment of hypoxia. Ferritin L subunit has been shown to have a number of potential mechanisms of action that could be used to treat hypoxia. For example, ferritin L subunit has been shown to increase the production of oxygen, which can help to improve the delivery of oxygen to tissues and organs.

In addition to these potential therapeutic applications, ferritin L subunit has also been shown to have a number of potential applications in other areas, including the treatment of

Protein Name: Ferritin Light Chain

Functions: Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity)

The "FTL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FTL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FTLP16 | FTLP2 | FTLP3 | FTLP7 | FTMT | FTO | FTO-IT1 | FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) | G Protein-Coupled Receptor Kinases (GRKs) | G0S2 | G2E3 | G2E3-AS1 | G3BP1 | G3BP2 | G6PC1 | G6PC2 | G6PC3 | G6PD | GA-binding protein | GAA | GAB1 | GAB2 | GAB3 | GAB4 | GABA(A) receptor | GABARAP | GABARAPL1 | GABARAPL2 | GABARAPL3 | GABBR1 | GABBR2 | GABPA | GABPAP | GABPB1 | GABPB1-AS1 | GABPB1-IT1 | GABPB2 | GABRA1 | GABRA2 | GABRA3 | GABRA4